Sunshine Biopharma, Inc. SBFM
0.84
0.04
5.00%
as of 25 Sep
- Market cap
- $3.3M
- P/E
- 0.0×
Follow SBFM
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (21.93%) | (27.33%) | (25.69%) | (24.35%) |
+8 more TTM periods Free account |
|
| (17.78%) | (21.15%) | (19.71%) | (19.47%) | ||
ROIC |
(26.67%) | (27.08%) | (27.97%) | (27.38%) | |
Return on Tangible Assets |
(22.85%) | (31.10%) | (28.50%) | (27.35%) | |
Average Days of Receivables |
41.67 | 41.25 | 34.78 | 40.64 | |
Free Cash Flow per Share |
(4.06) | (13.12) | (14.84) | (17.57) | |
Free Cash Flow |
(5.54) | (6.44) | (6.17) | (8.00) | |
Capital Expenditures |
(0.18) | (0.73) | (0.84) | (0.88) | |
Piotroski F-Score |
3.00 | 3.00 | 3.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
(12.97%) | (20.08%) | (16.58%) | (21.25%) | |
Accounts Receivable Turnover |
9.27 | 9.52 | 9.91 | 10.12 | |
Accounts Payable Turnover |
5.11 | 4.70 | 4.29 | 4.86 | |
Inventory Turnover |
1.96 | 1.90 | 1.94 | 2.09 | |
Average Days of Payables |
71.89 | 78.33 | 85.96 | 89.59 | |
Days of Inventory on Hand |
179.59 | 202.06 | 204.46 | 205.30 | |
Tax Rate |
0.00 | 0.01 | 0.00 | (0.08) | |
Research and Development Expense of Revenue |
0.67% | 1.19% | 1.66% | 1.82% | |
Selling, General and Administrative Expense of Revenue |
48.29% | 48.65% | 48.33% | 43.53% | |
Share Based Compensation of Revenue |
0.27% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.92 | 0.95 | 0.89 | 1.19 | |
Depreciation/Fixed assets |
2.17 | 4.05 | 3.73 | 3.20 | |
Capex/Depreciation |
(0.18) | (0.35) | (0.40) | (0.46) | |
Revenue per Share |
25.89 | 72.35 | 87.34 | 81.92 | |
Operating CF per Share |
(3.92) | (11.64) | (12.82) | (15.63) | |
Capex per Share |
(0.13) | (1.49) | (2.01) | (1.94) | |
Capex to Sales |
0.01 | 0.02 | 0.02 | 0.02 | |
Net Profit Margin |
(16.50%) | (17.02%) | (16.46%) | (16.06%) |
Columns are period end dates